Cargando…

Bebtelovimab: considerations for global access to treatments during a rapidly evolving pandemic

Detalles Bibliográficos
Autores principales:	Nichols, Russell M, Deveau, Carmen, Upadhyaya, Himanshu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512274/ https://www.ncbi.nlm.nih.gov/pubmed/36174596 http://dx.doi.org/10.1016/S1473-3099(22)00592-8

Ejemplares similares

A monoclonal antibody stands out against omicron subvariants: a call to action for a wider access to bebtelovimab
por: Hentzien, Maxime, et al.
Publicado: (2022)

Bebtelovimab-Induced Bradycardia Leading to Cardiac Arrest
por: Gearges, Christina, et al.
Publicado: (2022)

Evaluation of Bebtelovimab for Treatment of Covid-19 During the SARS-CoV-2 Omicron Variant Era
por: McCreary, Erin K, et al.
Publicado: (2022)

Considerations for ventilator triage during the COVID-19 pandemic
por: Feinstein, Max M, et al.
Publicado: (2020)

The effect of bebtelovimab on clinical outcomes in patients with COVID-19: A meta-analysis
por: Luo, Jie, et al.
Publicado: (2023)

Comment on “Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position”
por: Arshad, Ali, et al.
Publicado: (2020)

Trials without borders—decentralized trials and ensuring access to novel cancer therapies during a global pandemic
por: Tan, A.C., et al.
Publicado: (2022)

Outcomes of Bebtelovimab Therapy in Patients With Solid Organ Transplantation With Mild and Moderate COVID-19
por: Kapur, Rohan, et al.
Publicado: (2023)

Real-world Clinical Outcomes of Bebtelovimab and Sotrovimab Treatment of High-risk Persons With Coronavirus Disease 2019 During the Omicron Epoch
por: Razonable, Raymund R, et al.
Publicado: (2022)

Real-world evaluation of bebtelovimab effectiveness during the period of COVID-19 Omicron variants, including BA.4/BA.5
por: Molina, Kyle C., et al.
Publicado: (2023)

Multiple benefits of implementing a hepatology rapid access clinic highlighted by the COVID-19 pandemic
por: Chitul, Mirela, et al.
Publicado: (2023)

LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
por: Westendorf, Kathryn, et al.
Publicado: (2022)

Bebtelovimab for High-Risk Outpatients With Early COVID-19 in a Large US Health System
por: Dryden-Peterson, Scott, et al.
Publicado: (2022)

Improved Prognosis in Cystic Fibrosis: Consideration for Intensive Care during the COVID-19 Pandemic
por: Ramos, Kathleen J., et al.
Publicado: (2020)

Vaccine hesitancy and access to psoriasis care during the COVID‐19 pandemic: findings from a global patient‐reported cross‐sectional survey
por: Bechman, Katie, et al.
Publicado: (2022)

Keeping trainees safe in a pandemic: the evolving role of medical simulation training
por: Deng, Aaron, et al.
Publicado: (2020)

Deep Mutational Scanning to Predict Escape from Bebtelovimab in SARS-CoV-2 Omicron Subvariants
por: Alcantara, Mellissa C., et al.
Publicado: (2023)

SARS-CoV-2 neutralizing antibody bebtelovimab – a systematic scoping review and meta-analysis
por: Liew, Mabel Nyit Yi, et al.
Publicado: (2023)

Do Not Neglect the Children: Considerations for COVID-19 Pandemic
por: Naseri, Amirreza, et al.
Publicado: (2020)

A rapid access clinic for psoriasis: first experiences
por: Reid, Claire, et al.
Publicado: (2022)

Coronary artery disease in patients with severe aortic stenosis undergoing valve replacement: a rapidly evolving field
por: Minten, Lennert, et al.
Publicado: (2023)

Simulation as a tool for assessing and evolving your current personal protective equipment: lessons learned during the coronavirus disease (COVID-19) pandemic
por: Lockhart, Shannon L., et al.
Publicado: (2020)

Management of Gynaecological oncology diseases during COVID-19 global pandemic
por: de Andrade Vieira, Marcelo, et al.
Publicado: (2020)

Considerations on the development of surgical techniques for the treatment of onychocryptosis()()
por: Miola, Anna Carolina, et al.
Publicado: (2021)

Optimizing Best Vascular Access Practice in Patients on Dialysis during the COVID-19 Pandemic Period
por: Georgiadis, George S., et al.
Publicado: (2021)

Evolving guidelines in the use of topical nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritis
por: Balmaceda, Casilda M
Publicado: (2014)

As the pandemic evolves, so must global monitoring of COVID-19
por: Castanon, A., et al.
Publicado: (2022)

Health inequity during the COVID-19 pandemic: a cry for ethical global leadership
por: Chiriboga, David, et al.
Publicado: (2020)

Forensic Pathologist’s Dilemma in the wake of COVID-19 Pandemic
por: Khajuria, Himanshu, et al.
Publicado: (2021)

Evolving ethics of COVID-19 challenge trials
por: Manheim, David
Publicado: (2021)

Comment on “Global Access to Handwashing: Implications for COVID-19 Control in Low-Income Countries”
por: Freeman, Matthew C., et al.
Publicado: (2020)

Rapid deployment of pathology services to a remote Australian quarantine setting during the COVID-19 pandemic
por: Branley, James, et al.
Publicado: (2020)

Comment on: Transforming ophthalmic education into virtual learning during COVID-19 pandemic: a global perspective
por: Tzoumas, Nikolaos, et al.
Publicado: (2020)

Response to “Comment on ‘Global Access to Handwashing: Implications for COVID-19 Control in Low-Income Countries’”
por: Brauer, Michael, et al.
Publicado: (2020)

Ensuring global access to COVID-19 vaccines: deployment strategies for refugees and migrants must not be forgotten
por: Buonsenso, Danilo, et al.
Publicado: (2021)

Rapidly evolving treatment paradigm and considerations for sequencing therapies in metastatic prostate cancer—a narrative review
por: Sagaram, Smitha, et al.
Publicado: (2021)

Can modeling of HIV treatment processes improve outcomes? Capitalizing on an operations research approach to the global pandemic
por: Xiong, Wei, et al.
Publicado: (2008)

Should global financing be the main priority for pandemic preparedness?
por: IJsselmuiden, Carel, et al.
Publicado: (2021)

COVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program During the Omicron Surge
por: Cochran, Willa, et al.
Publicado: (2022)

Global 30-day outcomes after bariatric surgery during the COVID-19 pandemic (GENEVA): an international cohort study
por: Singhal, Rishi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lerjacov4mj65ngp7j3t0pqnhq